|
|
First Annual CER Symposium:
"Responding to the National CER Agenda: Evolving Data Sources and Analytics"
|
On Tuesday, June 15, 2010, the Center hosted Carolyn Clancy, MD, Director, Agency for Healthcare Research and Quality (AHRQ) as the morning keynote speaker and David Blumenthal, MD, Chairman, Office of the National Coordinator for Health Information Technology, as the lunch keynote speaker at an invitation-only symposium in Washington, DC with senior government officials, policy and thought leaders, and academics focused on comparative effectiveness research (CER).
The focus of the symposium was the role that data will play in the implementation of CER projects. Speakers and panels covered the uses of new data sources in CER and ways to link claims data to outcomes; the limits of randomized clinical trials in CER; propensity scoring, selection bias, and decomposition analysis; and HIPAA constraints, privacy and confidentiality.
At right, you can download the summary whitepaper. Below you will find complete video of the two keynote addresses, and video segments and slide presentations from the panelists.
|
Download the Symposium Summary white paper
|
Morning Keynote
Carolyn M. Clancy, MD
Director
Agency for Healthcare Research and Quality (AHRQ)
U.S. Department of Health and Human Services
Full video of Keynote "AHRQ's Role in Advancing CER"
Lunch Keynote
David Blumenthal, MD
Chairman
Office of the National Coordinator for Health Information Technology
Full Video of Keynote Address: "The Pathway to Data Liquidity"
Panel – "What Are the Limits of RCTs and Other Clinical Trials for CER? Then What?"
 Video |
Clifford Goodman, PhD
Vice President and Acting Director
The Lewin Group Center for Comparative Effectiveness Research
Slide presentation
|
 Video |
Michael S. Lauer, MD
Director, Division of Cardiovascular Sciences (DCVS)
National Heart, Lung, and Blood Institute (NHLBI), NIH
Slide presentation
|
 Video |
Sheldon Greenfield, MD
Executive Director
Health Policy Research Institute, University of California, Irvine
Slide presentation
|
 Video |
Eleanor Perfetto, PhD
Senior Director, Reimbursement & Regulatory Affairs
Pfizer, Inc.
Slide presentation
|
 |
Video summary of Introductory Panel |
Panel – "Issues in Propensity Scoring, Selection Bias, and Decomposition Analysis"
Panel – "What Are the New Data Sources? Linking Claims Data to Outcomes"
 Video |
|
 Video |
Mary L. Durham, PhD
Senior Investigator and Director, The Center for Health Research and
Vice President/Research, Kaiser Permanente
Slide presentation
|
Panel – "HIPAA Constraints, Privacy and Confidentiality in Today's Research Environment"
|
|
|
|